EDEN — Eden Research Income Statement
0.000.00%
- £13.07m
- £11.83m
- £4.30m
- 47
- 24
- 25
- 19
Annual income statement for Eden Research, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.37 | 1.23 | 1.83 | 3.19 | 4.3 |
| Cost of Revenue | |||||
| Gross Profit | 0.632 | 0.561 | 0.83 | 1.77 | 1.87 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.9 | 4.44 | 4.39 | 10 | 6.49 |
| Operating Profit | -2.54 | -3.21 | -2.57 | -6.84 | -2.19 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.55 | -3.4 | -2.57 | -6.92 | -2.18 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.26 | -2.78 | -2.24 | -6.49 | -1.91 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.27 | -2.79 | -2.24 | -6.49 | -1.91 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.27 | -2.79 | -2.24 | -6.49 | -1.91 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.006 | -0.007 | -0.006 | -0.008 | -0.004 |
| Dividends per Share |